

Fundamental dimension Equity attribute | CRTOPeer $14.88▲+0.07% Cap $729.1MP/E 7.4x QuantScore58/100 | DSPLeader $13.81▲+1.54% Cap $918.3MP/E 32.5x QuantScore71/100 | MGNIPeer $22.89▼-1.04% Cap $3.28BP/E 19.6x QuantScore53/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
46/100 |
93/100 |
47/100 |
Valuation Multiples, PEG & DCF upside | 100/100 | 57/100 | 68/100 |
Health Piotroski, Altman Z, leverage & liquidity | 64/100 | 72/100 | 43/100 |
Growth Revenue / earnings growth & margins | 29/100 | 54/100 | 52/100 |
Sentiment Analyst ratings, targets & revisions | 50/100 | 81/100 | 55/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | 7.4x | 32.5x | 19.6x |
Forward P/E (next FY) | 4.3x | 77.3x | 20.2x |
EV / EBITDA (TTM) | 2.3x | 28.3x | 19.8x |
Price / Sales | 0.4x | 2.4x | 4.4x |
Price / Free Cash Flow | 4.1x | 17.0x | 15.5x |
PEG ratio | -0.38 | 0.18 | 0.07 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 7 / 9 | 5 / 9 | 8 / 9 |
Altman Z-Score | 2.24 (Grey) | 4.07 (Safe) | 1.10 (Distress) |
Total debt / equity | 0.13 | 0.20 | 0.45 |
Quick ratio | 1.3x | 2.3x | 1.0x |
Interest coverage | 54.6x | — | 5.2x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | +0.6% | +19.0% | +6.9% |
Net income growth YoY | +29.6% | +253.6% | +534.7% |
Gross margin (TTM) | 53.6% | 44.5% | 64.8% |
Operating margin (FY) | 10.4% | 3.5% | 13.7% |
FCF margin (FY) | 10.7% | 15.0% | 23.2% |
5. Trailing price performancePrice change over period |
1M return | -10.1% | +11.9% | -4.9% |
3M return | -27.2% | +29.1% | +23.7% |
6M return | -22.0% | +30.8% | +76.3% |
Year to date | -27.8% | +14.7% | +41.0% |
1Y return | -27.5% | +50.9% | +14.8% |
3Y return | -48.2% | +160.6% | +221.0% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $287.63 +1833.0% upside | $1.04 -92.5% premium | $13.44 -41.3% premium |
Wall Street consensus target | $22.08 +48.4% · range $18.00–$25.00 | $18.83 +36.4% · range $17.50–$20.00 | $28.00 +22.3% · range $25.00–$32.00 |
Consensus stance | 60% Buy37% Hold3% Sell | 92% Buy8% Hold0% Sell | 59% Buy28% Hold13% Sell |